Information  X 
Enter a valid email address

EPIC/TIDM matching 'ABA'

Date
Time Source
Company
Announcement
09 May 2018 7:00 am RNS   AIM Cancellation - Abaco Capital plc
08 May 2018 12:13 pm RNS Factsheet Abaco Capital PLC (ABA) Result of AGM and Notice of Cancellation
  7:30 am RNS   AIM Suspension - Abaco Capital plc
04 May 2018 7:00 am RNS Factsheet Abaco Capital PLC (ABA) Suspension of trading on AIM
06 Apr 2018 7:00 am RNS Factsheet Abaco Capital PLC (ABA) Final Results
  7:00 am RNS Factsheet Abaco Capital PLC (ABA) Proposed Cancellation of Admission
27 Feb 2018 7:00 am RNS Factsheet Abaco Capital PLC (ABA) Strategy update
21 Dec 2017 10:00 am RNS Factsheet Oxford Pharmascience (ABA) Completion of Demerger
19 Dec 2017 3:50 pm RNS Factsheet Oxford Pharmascience (ABA) Confirmation of Capital Reductions
04 Dec 2017 2:14 pm RNS Factsheet Oxford Pharmascience (ABA) Subdivision of Capital
29 Nov 2017 7:00 am RNS Factsheet Oxford Pharmascience (ABA) FDA Advice on OXPzero Ibuprofen OTC Opportunity
27 Nov 2017 11:55 am RNS Factsheet Oxford Pharmascience (ABA) Result of General Meeting
22 Nov 2017 2:48 pm RNS Factsheet Oxford Pharmascience (ABA) Holding(s) in Company
  9:39 am RNS Factsheet Oxford Pharmascience (ABA) Holding(s) in Company
20 Nov 2017 4:40 pm RNS Factsheet Oxford Pharmascience (ABA) Second Price Monitoring Extn
  4:35 pm RNS Factsheet Oxford Pharmascience (ABA) Price Monitoring Extension
  7:00 am RNS Factsheet Oxford Pharmascience (ABA) MPA Advice on OXPzeroT Ibuprofen OTC Opportunity
10 Nov 2017 7:00 am RNS Factsheet Oxford Pharmascience (ABA) Announcement of demerger
02 Oct 2017 10:15 am RNS Factsheet Oxford Pharmascience (ABA) MHRA Advice on OXPzeroT Ibuprofen OTC Opportunity
25 Sep 2017 7:00 am RNS Factsheet Oxford Pharmascience (ABA) Interim Results
19 Jun 2017 11:38 am RNS Factsheet Oxford Pharmascience (ABA) Result of AGM
08 Jun 2017 7:00 am RNS Factsheet Oxford Pharmascience (ABA) Further Update re: OXPzero Ibuprofen Programmes
09 May 2017 7:00 am RNS Factsheet Oxford Pharmascience (ABA) Update regarding OXPzeroTM Ibuprofen Programmes
31 Mar 2017 9:05 am RNS Factsheet Oxford Pharmascience (ABA) Second Price Monitoring Extn
  9:00 am RNS Factsheet Oxford Pharmascience (ABA) Price Monitoring Extension
  7:00 am RNS Factsheet Oxford Pharmascience (ABA) FDA Feedback on OXPzeroT Ibuprofen Rx Programme
10 Mar 2017 7:00 am RNS Factsheet Oxford Pharmascience (ABA) Final Results
07 Mar 2017 7:00 am RNS Factsheet Oxford Pharmascience (ABA) Notice of Results
23 Feb 2017 7:00 am RNS Factsheet Oxford Pharmascience (ABA) Company Update
17 Jan 2017 7:00 am RNS Factsheet Oxford Pharmascience (ABA) Company Update
09 Nov 2016 7:00 am RNS Factsheet Oxford Pharmascience (ABA) R&D Update
07 Sep 2016 7:00 am RNS Factsheet Oxford Pharmascience (ABA) Interim results for the 6 months to 30 June 2016
20 Jul 2016 7:00 am RNS Factsheet Oxford Pharmascience (ABA) Commercial Update & Directorate Change
22 Jun 2016 5:31 pm RNS Factsheet Oxford Pharmascience (ABA) Result of AGM
20 May 2016 7:00 am RNS Factsheet Oxford Pharmascience (ABA) Shares Magazine Investor Evening Presentation
22 Apr 2016 12:18 pm RNS Factsheet Oxford Pharmascience (ABA) OXP to exhibit at the Master Investor Show 2016
19 Apr 2016 7:00 am RNS Factsheet Oxford Pharmascience (ABA) Positive Regulatory Advice from MHRA
11 Mar 2016 7:00 am RNS Factsheet Oxford Pharmascience (ABA) Grant of Share Options
04 Mar 2016 7:00 am RNS Factsheet Oxford Pharmascience (ABA) Final Results
01 Mar 2016 3:32 pm RNS Factsheet Oxford Pharmascience (ABA) Notice of Results
25 Feb 2016 7:00 am RNS Factsheet Oxford Pharmascience (ABA) Appointment of Director
29 Jan 2016 11:00 am RNS Factsheet Oxford Pharmascience (ABA) Change of Registered Office
25 Jan 2016 7:00 am RNS Factsheet Oxford Pharmascience (ABA) Entering Partnering Discussions
04 Dec 2015 11:42 am RNS Factsheet Oxford Pharmascience (ABA) Grant of Share Options
01 Dec 2015 3:06 pm RNS Factsheet Oxford Pharmascience (ABA) Holding(s) in Company
05 Nov 2015 7:00 am RNS Factsheet Oxford Pharmascience (ABA) Successful Completion of PoC for OXPzero Ibuprofen
22 Sep 2015 7:00 am RNS Factsheet Oxford Pharmascience (ABA) Interim results for the 6 months to 30 June 2015
16 Sep 2015 7:00 am RNS Factsheet Oxford Pharmascience (ABA) Notice of Interim Results
12 Aug 2015 7:00 am RNS Factsheet Oxford Pharmascience (ABA) Preliminary PK Data & Initiation of Further Study
31 Jul 2015 7:00 am RNS Factsheet Oxford Pharmascience (ABA) Results from Pilot Clinical Study of OXP500
16 Jul 2015 7:00 am RNS Factsheet Oxford Pharmascience (ABA) Initiation of Pilot Clinical Study for Ibuprofen
  7:00 am RNS Factsheet Oxford Pharmascience (ABA) Initiation of Pilot Clinical Study
06 Jul 2015 12:07 pm RNS Factsheet Oxford Pharmascience (ABA) Holding(s) in Company
30 Jun 2015 2:57 pm RNS Factsheet Oxford Pharmascience (ABA) Holding(s) in Company
  11:21 am RNS Factsheet Oxford Pharmascience (ABA) Holding(s) in Company
  11:02 am RNS Factsheet Oxford Pharmascience (ABA) Holding(s) in Company
  11:02 am RNS Factsheet Oxford Pharmascience (ABA) Holding(s) in Company
29 Jun 2015 4:02 pm RNS Factsheet Oxford Pharmascience (ABA) Holding(s) in Company
  2:13 pm RNS Factsheet Oxford Pharmascience (ABA) Holding(s) in Company
24 Jun 2015 3:37 pm RNS Factsheet Oxford Pharmascience (ABA) Result of GM


Company Announcements Archive »


a d v e r t i s e m e n t